CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic stem cell based therapy for diabetes to clinical trials. For more info, see our diabetes fact sheet: cirm.ca.gov/T1D_facts

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…